April 2026
The global cancer monoclonal antibodies market size reached USD 125.10 billion in 2025 and is predicted to hit around USD 658.07 billion by 2035, with a solid CAGR of 18.06%.
March 2026
The global veterinary monoclonal antibodies market size is estimated to hit around USD 5.62 billion by 2035 increasing from USD 1.74 billion in 2025, with a CAGR of 12.44%.
January 2026
The global monoclonal antibodies market size is evaluated at USD 286.32 billion in 2025 and is projected to hit around USD 880.01 billion by 2035, with a CAGR of 11.88%.
August 2025
The global immuno-oncology antibodies market is growing. Learn about market drivers, therapeutic applications, and the companies driving innovation.
June 2026
The solid tumor cancer treatment market size was valued at USD 5.64 billion in 2025 and is projected to hit around USD 9.14 billion by 2035 with a CAGR of 4.95%.
June 2026
The global oral cancer rapid test kit market size is estimated to hit around USD 3.94 billion by 2035 increasing from USD 2.38 billion in 2025, with a CAGR of 5.17%.
June 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
June 2026
The colorectal cancer diagnostics market size reached USD 16.9 billion in 2025 and is estimated to hit around USD 38.66 billion by 2035 with a CAGR of 8.63%.
June 2026
The global bispecific antibodies market size is valued at USD 17.99 billion in 2025 and is expected to attain around USD 603.13 billion by 2035 at a CAGR of 42.08%.
June 2026
The global breast cancer therapeutics market size was valued at USD 33.45 billion in 2025 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
June 2026
The global endometrial cancer market size is valued at USD 31.09 billion in 2025 and is projected to hit around USD 53.76 billion in 2035 with a CAGR of 5.63%.
June 2026
The global lung cancer surgery market size was evaluated at USD 1.55 billion in 2025 and is predicted to hit around USD 2.76 billion by 2035, growing at a CAGR of 5.95%.
May 2026
The global biosimilar monoclonal antibody market size is projected to hit around USD 124.43 billion by 2035 from USD 16.01 billion in 2025 with a CAGR of 22.76%.
May 2026
The global next-generation cancer diagnostics market size is projected to hit around USD 46.43 billion by 2035 from USD 19.16 billion in 2025, with a CAGR of 9.25%.
May 2026
The pancreatic cancer market size was estimated at USD 3.25 billion in 2025 and it is expected to be hit around USD 11.47 billion by 2035 at a CAGR of 13.44%.
May 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
May 2026
The global cancer biological therapy market size is expected to increase from USD 124.44 billion in 2025 and is predicted to reach at USD 266.75 billion by 2035, with a solid CAGR of 7.99%.
May 2026
The global CAR-T therapies for blood cancers market size was evaluated at USD 6.80 billion in 2025 and is predicted to hit around USD 38.40 billion by 2035, growing at a CAGR of 18.90%.
April 2026
The cancer gene therapy market size was estimated at USD 4.14 billion in 2025 and is projected to hit around USD 22.32 billion by 2035 with a CAGR of 18.35%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
April 2026
The global esophageal cancer market size is estimated to hit around USD 36.51 billion by 2035 increasing from USD 16.65 billion in 2025, with a CAGR of 8.17%.
April 2026
The global liver cancer drug market size is evaluated at USD 4.39 billion in 2025 and is predicted to hit around USD 22.35 billion by 2035, growing at a CAGR of 17.67%.
April 2026
The global stomach cancer treatment market size is estimated to surpass around USD 19.42 billion by 2035 from USD 6.08 billion in 2025, with a solid CAGR of 12.31%.
April 2026
The global ovarian cancer drugs market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 7.78 billion by 2035, growing at a CAGR of 6.64%.
March 2026
The global cancer biologics market size was valued at USD 117.45 billion in 2025 and is expected to hit around USD 235.81 billion by 2035 with a CAGR of 7.22%.
March 2026
The cervical cancer diagnostic market size accounted for USD 9.82 billion in 2025 and is expected to hit around USD 16.04 billion by 2035 with a CAGR of 5.03%.
March 2026
The global kidney cancer drugs market size is calculated at USD 7.24 billion in 2025 and is projected to hit around USD 12.16 billion by 2035 with a CAGR of 5.32%.
March 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 1.93 billion in 2025 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
March 2026
The global cancer registry software market size is expected to increase from USD 84.16 million in 2025 to hit around USD 273.29 million by 2034, with a CAGR of 12.50%.
March 2026
The global bispecific antibodies CDMO market expands with demand for next-generation therapeutics, advanced expression systems, and regulatory compliance expertise.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com